BlackRock Inc. - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 163 filers reported holding WUXI PHARMATECH CAYMAN INC in Q1 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$18,472,000
-2.6%
427,489
-4.7%
0.03%
+3.6%
Q2 2015$18,964,000
+34.3%
448,754
+23.2%
0.03%
+40.0%
Q1 2015$14,120,000
+52.9%
364,102
+32.8%
0.02%
+53.8%
Q4 2014$9,234,000
+95.8%
274,218
+103.7%
0.01%
+85.7%
Q3 2014$4,716,000
+154.0%
134,646
+138.2%
0.01%
+133.3%
Q2 2014$1,857,000
+18.0%
56,525
+32.3%
0.00%0.0%
Q1 2014$1,574,000
+87.2%
42,719
+95.0%
0.00%
+200.0%
Q4 2013$841,000
+26.3%
21,905
-9.8%
0.00%0.0%
Q3 2013$666,000
+29.1%
24,293
-1.2%
0.00%0.0%
Q2 2013$516,00024,5780.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q1 2014
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,762,017$64,948,0007.10%
Coupland Cardiff Asset Management LLP 261,361$9,634,0006.70%
Sloane Robinson LLP 160,100$5,901,0003.50%
Myriad Asset Management Ltd. 418,728$15,434,0003.07%
Granite Point Capital Management, L.P. 102,000$3,760,0002.69%
GRATRY & Co LLC 191,545$7,060,0002.54%
Consonance Capital Management LP 430,889$15,883,0002.36%
Grandeur Peak Global Advisors, LLC 263,135$9,699,0002.29%
Mirae Asset Global Investments Co., Ltd. 2,356,378$86,856,0002.20%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 91,460$3,371,0001.60%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders